Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression - A Free Webinar from the Brain & Behavior Research Foundation
04 mai 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, May 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression” on...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
16 avr. 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...
Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
12 mars 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
Nexstim Receives Two NBS System Orders from Hospitals in Norway and the US
04 mars 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 4 March 2021 at 10.00 am (EET) Nexstim Receives Two NBS System Orders from Hospitals in Norway and the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Abp lämnar uppmuntrande resultat från den första pilotstudien i svår depression vid Kuopio universitetssjukhus
03 mars 2021 02h00 HE
|
Nexstim Oyj
Företagsmeddelande, insiderinformation, Helsingfors, 3 mars 2021 kl. 9.00 (EET) Nexstim Abp lämnar uppmuntrande resultat från den första pilotstudien i svår depression vid Kuopio...
Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta pilottitutkimuksesta
03 mars 2021 02h00 HE
|
Nexstim Oyj
Yhtiötiedote, sisäpiiritieto, Helsinki, 3.3.2021 klo 9.00 (EET) Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta...
Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital
03 mars 2021 02h00 HE
|
Nexstim Oyj
Company announcement, Inside information, Helsinki, 3 March 2021 at 9.00 am (EET) Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University...
New Study Presents Impressive Results of Nexstim SmartFocus® nTMS Language Mapping
13 janv. 2021 06h00 HE
|
Nexstim Oyj
Press release, Helsinki, 13 January 2021 at 13.00 (EET) New Study Presents Impressive Results of Nexstim SmartFocus® nTMS Language Mapping Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Has Received Three New NBS System Orders
22 déc. 2020 02h30 HE
|
Nexstim Oyj
Press release, Helsinki, 22 December 2020 at 9.30 am (EET) Nexstim Has Received Three New NBS System Orders Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has...
Nexstim Has Received Two New NBT® System Purchase Orders in the United States
10 déc. 2020 05h30 HE
|
Nexstim Oyj
Press release, Helsinki, 10 December 2020 at 12.30 pm (EET) Nexstim Has Received Two New NBT® System Purchase Orders in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...